DCM
Driehaus Capital Management Portfolio holdings
AUM
$12.5B
1-Year Return
79.21%
This Quarter Return
+34.49%
1 Year Return
+79.21%
3 Year Return
+526.69%
5 Year Return
+1,716.36%
10 Year Return
+17,720.68%
AUM
$12.5B
AUM Growth
+$2.12B
(+20%)
Cap. Flow
+$593M
Cap. Flow
% of AUM
4.74%
Top 10 Holdings %
Top 10 Hldgs %
16.94%
Holding
522
New
128
Increased
126
Reduced
142
Closed
106
Top Buys
| 1 |
Credo Technology Group
CRDO
|
$136M |
| 2 |
HDFC Bank
HDB
|
$110M |
| 3 |
Astera Labs
ALAB
|
$104M |
| 4 |
StoneCo
STNE
|
$100M |
| 5 |
Core Scientific
CORZ
|
$98.1M |
Top Sells
| 1 |
Yum China
YUMC
|
$110M |
| 2 |
Sprouts Farmers Market
SFM
|
$97.6M |
| 3 |
Elastic
ESTC
|
$78.4M |
| 4 |
Compass
COMP
|
$71.9M |
| 5 |
Embraer
ERJ
|
$71.8M |
Sector Composition
| 1 | Technology | 25.59% |
| 2 | Industrials | 19.57% |
| 3 | Healthcare | 18.74% |
| 4 | Financials | 10.53% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Soleno Therapeutics
SLNO
$3.71B
| $32.2M | 0.26% |
384,273
+136,536
| +55% | +$11.4M |
|
127
Trip.com Group
TCOM
$47.6B
| $32M | 0.26% |
545,876
-285,406
| -34% | -$16.7M |
|
|
VRNA
128
Verona Pharma
VRNA
$9.2B
| $32M | 0.26% |
+338,360
| New | +$32M |
|
129
Cheesecake Factory
CAKE
$3.02B
| $31.8M | 0.25% |
507,614
-473,068
| -48% | -$29.6M |
|
130
ESAB
ESAB
$7.15B
| $31.8M | 0.25% |
263,442
-49,132
| -16% | -$5.92M |
|
131
Spyre Therapeutics
SYRE
$1.03B
| $31.2M | 0.25% |
2,085,590
-631,722
| -23% | -$9.46M |
|
132
Core & Main
CNM
$12.7B
| $31M | 0.25% |
513,083
+30,955
| +6% | +$1.87M |
|
133
American Superconductor
AMSC
$2.21B
| $30.8M | 0.25% |
839,847
+4
| +0% | +$147 |
|
134
Penumbra
PEN
$11B
| $30.4M | 0.24% |
118,643
+42,365
| +56% | +$10.9M |
|
135
Guidewire Software
GWRE
$22B
| $30.3M | 0.24% |
128,576
+14,470
| +13% | +$3.41M |
|
136
Vita Coco
COCO
$2.19B
| $29.9M | 0.24% |
827,788
-149,503
| -15% | -$5.4M |
|
|
MRX
137
Marex Group
MRX
$2.55B
| $29.7M | 0.24% |
+753,652
| New | +$29.7M |
|
138
BrightView Holdings
BV
$1.36B
| $29.2M | 0.23% |
1,756,476
-10,996
| -0.6% | -$183K |
|
139
Comfort Systems
FIX
$24.9B
| $29.1M | 0.23% |
+54,337
| New | +$29.1M |
|
140
TG Therapeutics
TGTX
$5.11B
| $29.1M | 0.23% |
807,833
+33,177
| +4% | +$1.19M |
|
141
Universal Technical Institute
UTI
$1.47B
| $28.8M | 0.23% |
848,676
+45,274
| +6% | +$1.53M |
|
142
Adaptive Biotechnologies
ADPT
$1.96B
| $28.2M | 0.23% |
2,423,590
+271,255
| +13% | +$3.16M |
|
143
TKO Group
TKO
$15.9B
| $28M | 0.22% |
154,024
+9,292
| +6% | +$1.69M |
|
144
GeneDx Holdings
WGS
$3.81B
| $28M | 0.22% |
303,455
-151,501
| -33% | -$14M |
|
145
Edgewise Therapeutics
EWTX
$1.64B
| $27.6M | 0.22% |
2,101,781
+726,039
| +53% | +$9.52M |
|
146
Genius Sports
GENI
$3.22B
| $26.7M | 0.21% |
2,566,596
-320,988
| -11% | -$3.34M |
|
147
Celsius Holdings
CELH
$15B
| $26.5M | 0.21% |
+572,254
| New | +$26.5M |
|
148
Innodata
INOD
$1.38B
| $26.2M | 0.21% |
512,210
-55,656
| -10% | -$2.85M |
|
149
Weatherford International
WFRD
$4.49B
| $26.1M | 0.21% |
+519,583
| New | +$26.1M |
|
150
Alnylam Pharmaceuticals
ALNY
$59.2B
| $26M | 0.21% |
79,714
+22,586
| +40% | +$7.37M |
|